TipRanks
Advertisement
Advertisement

RGNX Stock Latest News

Regenxbio presents positive 3-year durability data for Surabgene Lomparvove
The FlyRegenxbio presents positive 3-year durability data for Surabgene Lomparvove
7d ago
RGNX
RegenXBio Reaches Patent Settlement Over AAV Gene Therapy
PremiumCompany Announcements
RegenXBio Reaches Patent Settlement Over AAV Gene Therapy
8d ago
8K
RGNX
Regenxbio director buys $949.4K in common stock
PremiumThe Fly
Regenxbio director buys $949.4K in common stock
1M ago
RGNX
RegenXBio reshapes board with new independent director
PremiumCompany Announcements
RegenXBio reshapes board with new independent director
1M ago
8K
RGNX
Regenxbio price target lowered to $21 from $23 at H.C. Wainwright
PremiumThe Fly
Regenxbio price target lowered to $21 from $23 at H.C. Wainwright
1M ago
RGNX
RGNX: Buy Rating Reiterated as RGX-202 BLA Catalyst Offsets MPS II Setbacks; $18 Price Target Maintained
PremiumRatingsRGNX: Buy Rating Reiterated as RGX-202 BLA Catalyst Offsets MPS II Setbacks; $18 Price Target Maintained
1M ago
RGNX
Regenxbio price target lowered to $29 from $32 at Baird
Premium
The Fly
Regenxbio price target lowered to $29 from $32 at Baird
1M ago
RGNX
Regenxbio price target lowered to $32 from $45 at Clear Street
Premium
The Fly
Regenxbio price target lowered to $32 from $45 at Clear Street
1M ago
RGNX
RegenXBio Faces RGX-121 Clinical Hold, Refocuses Pipeline
PremiumCompany Announcements
RegenXBio Faces RGX-121 Clinical Hold, Refocuses Pipeline
1M ago
8K
RGNX
BofA says Regenxbio’s MPS setback ‘disappointing,’ larger catalysts intact
PremiumThe Fly
BofA says Regenxbio’s MPS setback ‘disappointing,’ larger catalysts intact
1M ago
RGNX
Video: Alibaba slips as shares offered to support AI investment
PremiumThe Fly
Video: Alibaba slips as shares offered to support AI investment
1M ago
NVT
PDD
Morning Movers: Regenxbio sinks following clinical hold on RGX-121
PremiumThe Fly
Morning Movers: Regenxbio sinks following clinical hold on RGX-121
1M ago
GGR
PDD
Regenxbio to resume trading at 7:25 am ET
PremiumThe FlyRegenxbio to resume trading at 7:25 am ET
1M ago
RGNX
Regenxbio reports FDA placed clinical hold on RGX-121
Premium
The Fly
Regenxbio reports FDA placed clinical hold on RGX-121
1M ago
RGNX
Regenxbio price target lowered to $23 from $26 at H.C. Wainwright
Premium
The Fly
Regenxbio price target lowered to $23 from $26 at H.C. Wainwright
2M ago
RGNX
Regenxbio price target raised to $18 from $16 at Morgan Stanley
PremiumThe Fly
Regenxbio price target raised to $18 from $16 at Morgan Stanley
2M ago
RGNX
Regenxbio downgraded to Equal Weight from Overweight at Barclays
PremiumThe Fly
Regenxbio downgraded to Equal Weight from Overweight at Barclays
2M ago
RGNX
Regenxbio reports Q2 EPS 43c vs. ($1.38) last year
PremiumThe Fly
Regenxbio reports Q2 EPS 43c vs. ($1.38) last year
2M ago
RGNX
RegenXBio Inc. (RGNX) Q2 Earnings Cheat Sheet
PremiumPre-Earnings
RegenXBio Inc. (RGNX) Q2 Earnings Cheat Sheet
2M ago
RGNX
RegenXBio Inc. (RGNX) Q2 Earnings Cheat Sheet
PremiumPre-EarningsRegenXBio Inc. (RGNX) Q2 Earnings Cheat Sheet
2M ago
RGNX
RegenXBio Raises Capital Through Public Equity Offering
Premium
Company Announcements
RegenXBio Raises Capital Through Public Equity Offering
2M ago
8K
RGNX
Regenxbio presents long-term data for surabgene lomparvovec
Premium
The Fly
Regenxbio presents long-term data for surabgene lomparvovec
2M ago
RGNX

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >